Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × eculizumab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

pembrolizumab 1054 Specimen Handling 696 Carboplatin 692 Cyclophosphamide 671 Magnetic Resonance Spectroscopy 651 Cisplatin 594 Nivolumab 569 Paclitaxel 522 Radiotherapy 467 Gemcitabine 462 Biopsy 425 Bevacizumab 382 Dexamethasone 374 fludarabine 338 Docetaxel 329 venetoclax 325 Oxaliplatin 303 atezolizumab 302 Capecitabine 299 Fluorouracil 299 Rituximab 288 durvalumab 279 Radiosurgery 261 Pemetrexed 259 Doxorubicin 255 Drug Therapy 254 Ipilimumab 253 Standard of Care 247 Radiation 239 Lenalidomide 238

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06764160 2026-01-15

ECU-MG-304

Alexion Pharmaceuticals, Inc.

Phase 3 Completed

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡